Tygh Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-12,075
| Closed | -$7.78M | – | 92 |
|
|
2021
Q2 | $7.78M | Sell |
12,075
-132
| -1% | -$85K | 1.06% | 44 |
|
|
2021
Q1 | $6.97M | Sell |
12,207
-7,837
| -39% | -$4.48M | 0.99% | 43 |
|
|
2020
Q4 | $11.7M | Sell |
20,044
-2,969
| -13% | -$1.73M | 1.82% | 9 |
|
|
2020
Q3 | $11.9M | Sell |
23,013
-1,821
| -7% | -$939K | 2.25% | 8 |
|
|
2020
Q2 | $11.2M | Sell |
24,834
-23,690
| -49% | -$10.7M | 2.34% | 7 |
|
|
2020
Q1 | $17M | Buy |
48,524
+396
| +0.8% | +$139K | 3.81% | 1 |
|
|
2019
Q4 | $17.8M | Buy |
48,128
+5,102
| +12% | +$1.89M | 2.94% | 3 |
|
|
2019
Q3 | $14.3M | Sell |
43,026
-74
| -0.2% | -$24.6K | 2.54% | 5 |
|
|
2019
Q2 | $13.5M | Buy |
43,100
+1,187
| +3% | +$371K | 2.29% | 8 |
|
|
2019
Q1 | $12.8M | Buy |
+41,913
| New | +$12.8M | 2.25% | 5 |
|
|
2018
Q4 | – | Sell |
-33,014
| Closed | -$10.3M | – | 79 |
|
|
2018
Q3 | $10.3M | Sell |
33,014
-974
| -3% | -$305K | 1.69% | 18 |
|
|
2018
Q2 | $9.81M | Buy |
33,988
+12,317
| +57% | +$3.55M | 1.66% | 17 |
|
|
2018
Q1 | $5.42M | Sell |
21,671
-5,591
| -21% | -$1.4M | 1.03% | 46 |
|
|
2017
Q4 | $6.51M | Sell |
27,262
-637
| -2% | -$152K | 1.22% | 27 |
|
|
2017
Q3 | $6.2M | Sell |
27,899
-7,557
| -21% | -$1.68M | 1.24% | 35 |
|
|
2017
Q2 | $8.02M | Buy |
35,456
+4,461
| +14% | +$1.01M | 1.82% | 7 |
|
|
2017
Q1 | $6.18M | Buy |
30,995
+1,099
| +4% | +$219K | 1.44% | 17 |
|
|
2016
Q4 | $5.45M | Buy |
+29,896
| New | +$5.45M | 1.37% | 27 |
|